Who owns Phathom Pharmaceuticals Inc?
- Ticker: PHAT
- CUSIP Number: 71722w107
Tip: Access positions for across all investors
Analyze quarterly positions in Phathom Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Phathom Pharmaceuticals stock
Who bought or sold Phathom Pharmaceuticals Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Frazier Life Sciences Management | 10M | $107M | 0% | Mar 2024 |
|
Medicxi Ventures Management | 7.5M | $79M | 98% | Mar 2024 |
|
Carlyle | 3.5M | $37M | 0% | Mar 2024 |
|
BlackRock | 2.7M | $29M | 13% | Mar 2024 |
|
Ensign Peak Advisors | 2.3M | $24M | 32% | Mar 2024 |
|
Vanguard Group | 2.0M | $21M | 1% | Mar 2024 |
|
NEA Management Company | 2.0M | $21M | 0% | Mar 2024 |
|
Avidity Partners Management | 1.7M | $18M | 1% | Mar 2024 |
|
683 Capital Management | 1.7M | $18M | 29% | Mar 2024 |
|
Jennison Associates | 1.6M | $18M | 100% | Mar 2024 |
|
Gilder, Gagnon, Howe & Co | 1.5M | $13M | 11% | Dec 2023 |
|
Propel Bio Management | 870k | $9.2M | 96% | Mar 2024 |
|
Decheng Capital | 850k | $7.8M | 100% | Dec 2023 |
|
Geode Capital Management | 751k | $8.0M | 10% | Mar 2024 |
|
Kennedy Capital Management | 572k | $6.1M | 0% | Mar 2024 |
|
Jennifer Ranahan | 568k | $6.0M | 1% | Mar 2024 |
|
Woodline Partners | 566k | $6.0M | -23% | Mar 2024 |
|
Simplify Asset Management | 522k | $5.5M | 119% | Mar 2024 |
|
Saturn V Capital Management | 501k | $5.3M | 100% | Mar 2024 |
|
Two Sigma Investments | 467k | $5.0M | 75% | Mar 2024 |
|
Octagon Capital Advisors | 455k | $4.8M | 810% | Mar 2024 |
|
Checkpoint Capital | 445k | $4.7M | 24% | Mar 2024 |
|
StepStone | 422k | $4.5M | 0% | Mar 2024 |
|
Damian Sousa | 305k | $3.2M | 100% | Mar 2024 |
|
Northern Trust | 283k | $3.0M | 5% | Mar 2024 |
|
Charles Schwab Investment Management | 265k | $2.8M | 1% | Mar 2024 |
|
Nuveen Asset Management | 262k | $2.8M | -9% | Mar 2024 |
|
Morgan Stanley | 237k | $2.5M | 203% | Mar 2024 |
|
Millennium Management | 225k | $2.4M | 32% | Mar 2024 |
|
Goldman Sachs Group | 207k | $2.2M | -1% | Mar 2024 |
|
Newtyn Management | 165k | $1.8M | -74% | Mar 2024 |
|
Wellington Management Company | 154k | $1.4M | 55% | Dec 2023 |
|
Citadel Advisors | 153k | $1.6M | 421% | Mar 2024 |
|
Schonfeld Strategic Advisors | 145k | $1.5M | 137% | Mar 2024 |
|
Jpmorgan Chase & Co | 139k | $1.5M | -5% | Mar 2024 |
|
Susquehanna International | 123k | $1.3M | 15% | Mar 2024 |
|
Moore Capital Management | 120k | $1.3M | 20% | Mar 2024 |
|
Bank of America Corporation | 106k | $1.1M | 29% | Mar 2024 |
|
Bank of New York Mellon | 95k | $1.0M | -10% | Mar 2024 |
|
D. E. Shaw & Co | 64k | $681k | -50% | Mar 2024 |
|
Penn Mutual Asset Management | 63k | $667k | 0% | Mar 2024 |
|
State of Wisconsin Investment Board | 59k | $629k | 25% | Mar 2024 |
|
Swiss National Bank | 56k | $595k | 0% | Mar 2024 |
|
Two Sigma Advisers | 52k | $548k | 127% | Mar 2024 |
|
UBS Group | 50k | $530k | 27% | Mar 2024 |
|
Rhumbline Advisers | 47k | $500k | -3% | Mar 2024 |
|
Credit Suisse | 40k | $421k | 4% | Mar 2024 |
|
Alliancebernstein | 38k | $344k | 0% | Dec 2023 |
|
Integrys Wealth Advisors | 35k | $373k | 0% | Mar 2024 |
|
Legal & General Group | 34k | $362k | 0% | Mar 2024 |
|
Creative Planning | 32k | $341k | 50% | Mar 2024 |
|
Occidental Asset Management | 30k | $315k | 0% | Mar 2024 |
|
California State Teachers Retirement System | 29k | $307k | -7% | Mar 2024 |
|
UBS O'Connor | 29k | $304k | 100% | Mar 2024 |
|
Barclays | 28k | $300k | -43% | Mar 2024 |
|
Jane Street | 25k | $266k | -62% | Mar 2024 |
|
Fulton Breakefield Broenniman d/b/a FBB Capital Partners | 24k | $250k | 0% | Mar 2024 |
|
Hanson McClain Advisors | 23k | $240k | 0% | Mar 2024 |
|
Springbok Capital Management | 22k | $234k | 100% | Mar 2024 |
|
Jacobs Levy Equity Management | 21k | $223k | -96% | Mar 2024 |
|
T. Rowe Price Associates | 20k | $208k | 12% | Mar 2024 |
|
SG Americas Securities | 19k | $200k | 4% | Mar 2024 |
|
MetLife Investment Advisors | 17k | $150k | 0% | Dec 2023 |
|
American International | 16k | $146k | 3% | Dec 2023 |
|
Algert Coldiron Investors | 15k | $136k | -84% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 14k | $151k | -19% | Mar 2024 |
|
GSA Capital Partners | 14k | $151k | 100% | Mar 2024 |
|
Mirae Asset Global Investments | 14k | $148k | 2% | Mar 2024 |
|
Ubs Global Asset Management Americas | 13k | $137k | 0% | Mar 2024 |
|
Stratos Wealth Advisors | 13k | $133k | 0% | Mar 2024 |
|
Entropy Technologies | 12k | $129k | -17% | Mar 2024 |
|
Wells Fargo & Company | 12k | $123k | 7% | Mar 2024 |
|
Florida State Board of Administration | 11k | $80k | 100% | Mar 2024 |
|
Ing Investment Management | 11k | $117k | -14% | Mar 2024 |
|
China Universal Asset Management | 11k | $117k | 66% | Mar 2024 |
|
Principal Financial Group | 11k | $115k | -7% | Mar 2024 |
|
Klingman & Associates | 10k | $110k | 100% | Mar 2024 |
|
Kestra Private Wealth Services | 10k | $106k | 100% | Mar 2024 |
|
Davenport & Co | 10k | $106k | 0% | Mar 2024 |
|
Staley Capital Advisers | 10k | $106k | 0% | Mar 2024 |
|
Virtus ETF Advisers | 9.7k | $103k | -6% | Mar 2024 |
|
Zurcher Kantonalbank | 7.1k | $75k | -14% | Mar 2024 |
|
Citigroup | 6.0k | $65k | 7% | Mar 2024 |
|
New York State Common Retirement Fund | 5.9k | $63k | 2% | Mar 2024 |
|
FNY Investment Advisers | 5.0k | $53k | 100% | Mar 2024 |
|
Us Bancorp | 3.5k | $37k | 100% | Mar 2024 |
|
Summit Investment Advisors | 3.1k | $33k | 0% | Mar 2024 |
|
FMR | 2.1k | $22k | 10% | Mar 2024 |
|
Royal Bank of Canada | 2.0k | $22k | -81% | Mar 2024 |
|
Metropolitan Life Insurance Company | 1.8k | $17k | 0% | Dec 2023 |
|
Cutler | 1.3k | $3.0k | -48% | Mar 2024 |
|
ICA Group Wealth Management | 1.3k | $14k | 0% | Mar 2024 |
|
Amalgamated Bank | 1.1k | $12k | -61% | Mar 2024 |
|
Huntington National Bank | 978.00 | $10k | 2% | Mar 2024 |
|
Tower Research Capital | 580.00 | $6.2k | -94% | Mar 2024 |
|
BFSG | 300.00 | $3.2k | 0% | Mar 2024 |
|
Advisor Group Holdings | 230.00 | $2.4k | -18% | Mar 2024 |
|
Bear Mountain Capital | 200.00 | $2.0k | 0% | Mar 2024 |
|
Daiwa Securities Group | 167.00 | $2.0k | 0% | Mar 2024 |
|
Pnc Financial Services | 166.00 | $1.8k | 23% | Mar 2024 |
|
Riggs Asset Managment | 69.00 | $733.000800 | 100% | Mar 2024 |
|
GAMMA Investing | 23.00 | $244.000100 | 229% | Mar 2024 |
|
Zrc Wealth Management | 20.00 | $213.000000 | 0% | Mar 2024 |
|
NISA Investment Advisors | 20.00 | $212.000000 | -33% | Mar 2024 |
|
Farther Finance Advisors | 17.00 | $179.999400 | -11% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 7.00 | $73.999800 | 100% | Mar 2024 |
|
CWM | 4.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Phathom Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
MPM Oncology Impact Management | Sep 2023 | 347k | $3.6M |
Altium Capital Management | Sep 2023 | 220k | $2.3M |
Walleye Trading Advisors | Dec 2023 | 202k | $1.8M |
EcoR1 Capital | Dec 2023 | 199k | $1.8M |
AlphaCentric Advisors | Sep 2023 | 160k | $1.7M |
Federated Investors | Sep 2023 | 82k | $852k |
Trexquant Investment | Sep 2023 | 59k | $610k |
Russell Investments | Dec 2023 | 39k | $359k |
Ohio Pers | Dec 2023 | 39k | $352k |
Graham Capital Management | Dec 2023 | 21k | $188k |
AQR Capital Management | Dec 2023 | 18k | $168k |
Tocqueville Asset Management | Dec 2023 | 18k | $165k |
ExodusPoint Capital Management | Sep 2023 | 17k | $176k |
Dynamic Technology Lab Private | Dec 2023 | 15k | $137k |
Landscape Capital Management | Dec 2023 | 15k | $136k |
XTX Topco | Sep 2023 | 15k | $154k |
Engineers Gate Manager | Sep 2023 | 13k | $134k |
Ameriprise Financial | Sep 2023 | 11k | $118k |
Quest Partners | Dec 2023 | 2.2k | $20k |
Headinvest | Sep 2023 | 882.00 | $9.0k |
Tradition Wealth Management | Dec 2023 | 500.00 | $5.0k |